NDC 73362-016-02 - Skytrofa

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 73362-016
Requested NDC: 73362-016-02
Package NDCs from labels: 73362-016-02, 73362-016-01
Manufacturer: Ascendis Pharma Endocrinology, Inc.
Effective date: 2026-07-23
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Skytrofa - Ascendis Pharma Endocrinology, Inc.	Ascendis Pharma Endocrinology, Inc.	2026-07-23	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
73362-016-01	Skytrofa	4 in 1 CARTON	INJECTION, POWDER, LYOPHILIZED,	4	11
73362-016-02	Skytrofa	1 in 1 CARTRIDGE	INJECTION, POWDER, LYOPHILIZED,	1	11
73362-016-02	Skytrofa	1 in 1 BLISTER PACK	INJECTION, POWDER, LYOPHILIZED,	1	11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
73362-016-01	EA - Each	73362-016	9a59f89a-51e8-411b-9de6-1789f9d1fdf1	1	2025-10-14
73362-016-02	EA - Each	73362-016	98e843c0-6282-477c-9eab-11bd320dc7d6	1	2025-10-14

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Skytrofa	LONAPEGSOMATROPIN-TCGD	Ascendis Pharma Endocrinology, Inc.	9229f871-bc61-4ddc-8122-d126d40e36ac	2026-07-23	Warnings, Adverse reactions	Exact identifier application number: BLA761177 ndc (package): 73362-008-02 ndc (package): 73362-013-02 ndc (package): 73362-003-02 ndc (package): 73362-005-01 ndc (package): 73362-004-01 ndc (package): 73362-004-02 ndc (package): 73362-014-01 ndc (package): 73362-010-02 ndc (package): 73362-007-01 ndc (package): 73362-016-02 ndc (package): 73362-015-01 ndc (package): 73362-006-01 ndc (package): 73362-008-01 ndc (package): 73362-012-02 ndc (package): 73362-009-02 ndc (package): 73362-016-01 ndc (package): 73362-012-01 ndc (package): 73362-005-02 ndc (package): 73362-011-01 ndc (package): 73362-006-02 ndc (package): 73362-015-02 ndc (package): 73362-011-02 ndc (package): 73362-010-01 ndc (package): 73362-013-01 ndc (package): 73362-014-02 ndc (package): 73362-009-01 ndc (package): 73362-003-01 ndc (package): 73362-007-02 ndc (product): 73362-008 ndc (product): 73362-010 ndc (product): 73362-012 ndc (product): 73362-011 ndc (product): 73362-006 ndc (product): 73362-014 ndc (product): 73362-003 ndc (product): 73362-009 ndc (product): 73362-007 ndc (product): 73362-005 ndc (product): 73362-016 ndc (product): 73362-013 ndc (product): 73362-015 ndc (product): 73362-004 ndc11 (package): 73362001602 rxcui: 2569623 rxcui: 2569609 rxcui: 2569611 rxcui: 2569619 rxcui: 2569635 rxcui: 2569605 rxcui: 2569617 rxcui: 2569631 rxcui: 2721799 rxcui: 2569607 rxcui: 2569627 rxcui: 2569615 rxcui: 2569629 rxcui: 2721803 rxcui: 2721791 rxcui: 2721787 rxcui: 2569633 rxcui: 2721795 rxcui: 2721785 rxcui: 2569637 rxcui: 2569603 rxcui: 2569613 rxcui: 2721797 rxcui: 2721801 rxcui: 2569621 rxcui: 2569625 rxcui: 2721793 rxcui: 2721789 spl id: 4b962793-361f-4194-8292-af51f5ceaabb spl set id: 9229f871-bc61-4ddc-8122-d126d40e36ac unii: OP35X9610Y

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.